Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
EVOQ Remedies Ltd (543500)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543500 NSE: Trading | Small Cap | EVOQ Remedies Share Price
₹1.53 0.07 (4.79%)
As on 28-Sep'26 16:01
EVOQ Remedies Ltd (543500)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543500 NSE: Trading | Small Cap | EVOQ Remedies Share Price
₹1.53 0.07 (4.79%)
As on 28-Sep'26 16:01
Key Metrics
Valuation Multiples
Market Cap
₹4 Cr.
Current Price
₹1.5
52-Week Low / High
₹1 / 6
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
39.4
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
190.37%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.02%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹24.9 Cr.
Face Value
₹10
All Time Low / High
₹1.35 / 25.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is EVOQ Remedies Ltd a good quality company?
EVOQ Remedies Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does EVOQ Remedies Ltd performance compare with that of its Peers?
Revenue growth of EVOQ Remedies Ltd vs industry peers?
EVOQ Remedies Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of EVOQ Remedies Ltd?
Promoters hold 0.02% of the EVOQ Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of EVOQ Remedies Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -52.47% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
EVOQ Remedies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 68.9% | 2.7% | 246.9% | 9.1% | 7% | 1.9% | 0.4% | - |
| Value Creation Index ⓘ | 3.9 | -0.8 | 16.6 | -0.4 | -0.5 | -0.9 | -1.0 | - |
Growth Parameters ⓘ |
||||||||
| Sales ⓘ | 3.3 | 9.1 | 10 | 16.8 | 20.4 | 4.1 | 11.8 | 26 |
| Sales YoY Gr. | - | 179.1% | 10.5% | 67.5% | 21.5% | -80.1% | 190.4% | - |
| Adj EPS ⓘ | 0.2 | 0 | 10.1 | 0.8 | 1.2 | 0.3 | 0 | -0.1 |
| YoY Gr. | - | -100% | NA | -92.1% | 48.8% | -72.3% | -87.9% | - |
| BVPS (₹) ⓘ | 0 | 0 | 10.5 | 17 | 18.2 | 18.6 | 17.9 | 17.9 |
| Adj Net Profit ⓘ | 0 | 0 | 0.7 | 1.1 | 1.6 | 0.5 | 0.1 | -0 |
| Cash Flow from Ops. ⓘ | 0 | -0 | 0 | -26.4 | -4.4 | 5.3 | -14.6 | - |
| Debt/CF from Ops. ⓘ | 0.2 | -0.3 | 0 | -0.3 | -2.2 | 0.8 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 5.3% | -11.2% | 190.4% | ||||
| Adj EPS ⓘ | NA | NA | -63.2% | -87.9% | ||||
| BVPSⓘ | NA | NA | 1.7% | -3.6% | ||||
| Share Price | - | - | -52.4% | -64.9% | ||||
Key Financial Parameters ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 49.8 | 1.3 | 186.9 | 9.1 | 6.8 | 1.8 | 0.3 | -0.6 |
| Op. Profit Mgn % ⓘ | 0.5 | 0 | 9.5 | 8.7 | -18.3 | -40.4 | -19 | NAN |
| Net Profit Mgn % ⓘ | 0.3 | 0 | 7.1 | 6.5 | 7.9 | 11.2 | 0.8 | -1 |
| Debt to Equity ⓘ | 0.1 | 0.3 | 0 | 0.4 | 0.4 | 0.2 | 0 | - |
| Working Cap Days ⓘ | 0 | 156 | 249 | 416 | 582 | 3,218 | 1,340 | 0 |
| Cash Conv. Cycle ⓘ | 0 | -34 | -38 | 268 | 402 | 1,008 | 148 | 0 |
Valuation of EVOQ Remedies - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
EVOQ Remedies Ltd FAQs
The current trading price of EVOQ Remedies on 28-Sep-2026 16:01 is ₹1.53.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of EVOQ Remedies stood at ₹3.64 Cr
The latest P/E ratio of EVOQ Remedies as of 27-Sep-2026 is 0.00.
The latest P/B ratio of EVOQ Remedies as of 27-Sep-2026 is 0.08.
The 52-week high of EVOQ Remedies is ₹6.11 and the 52-week low is ₹1.35.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EVOQ Remedies is ₹25.51 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that EVOQ Remedies Ltd is a below average quality company.
The key valuation ratios of EVOQ Remedies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of EVOQ Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About EVOQ Remedies Ltd
EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.
In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.
EVOQ majorly does trading in following segments of pharmaceuticals raw materials:
- Excipients
- Nutraceuticals
- Pellets
- Solvents
- Sweetners
- Vitamins
- Amino Acids
- Bulk Drugs
- Dairy Products
- Active Pharmaceuticals Ingredients
Business area of the company
The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.
Major events:
- 2010: Incorporation of Company as ‘Salus Life Science and Research Private Limited’ at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956.
- 2021: Conversion of the Company into public limited company, the name of the company was changed to ‘Evoq Remedies Limited’ and fresh Certificate of Incorporation dated July 28, 2021 was issued by Registrar of Companies, Ahmedabad.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
